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Objective: Available evidence about the role of supplementary vitamin E in normal pregnancy 
is inadequate. This study assessed the potential benefit of vitamin E supplementation on some 
pregnancy health indices.
Methods: A 1:2 weighted simple randomization technique was used to allocate 104 eligible 
pregnant women to receive vitamin E and 168 women (control) not to receive the drug. Treated 
women received capsules containing 400 IU vitamin E from week 14 of gestation to the end 
of the pregnancy.
Results: Background variables including maternal age were found to be similarly distributed 
between the study groups. The rate of maternal and perinatal outcomes including Apgar score 
and birth weight did not differ significantly between groups. Preeclampsia occurred in 1% of 
treated women vs 1.78% of control women.
Conclusion: Giving supplemental vitamin E from the second trimester of pregnancy did not 
appear to affect the risk of pregnancy outcomes and occurrence of preeclampsia.
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Introduction
Improving maternity outcomes has always been the focus of interest in reproductive 
health research and researchers have conducted many observational and interventional 
studies to assess factors or agents affecting pregnancy outcome. Among these are 
some neonatal outcomes such as Apgar score and birth weight. Preeclampsia has also 
been the focus of interest in such research. Preeclampsia is a common complication 
in human pregnancy and is a major source of perinatal morbidity and mortality 
  worldwide. It has been shown recently that preeclampsia may even affect maternal 
health after pregnancy.1
The vital role of vitamin E in reproduction was first investigated 80 years ago.2 
Unlike many in vitro studies, promising evidence for the antioxidant properties of 
vitamin E related to specific outcomes is scarce.3 The magic of antioxidants has 
provided a good motivation for researchers to study effects of antioxidants on   pregnancy 
outcomes and also on preeclampsia.4 Vitamin E has also gained some attention in 
this regard. Some studies have compared the serum concentrations of vitamin E in 
different conditions during pregnancy and some have investigated the role of supple-
mentary vitamin E in improving pregnancy outcomes. However, a recent systematic 
review suggested that the available evidence is inadequate to conclude that vitamin 
E supplementation, either alone or in combination with other supplements, can be 
beneficial during pregnancy.5International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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The aim of this study was to assess the potential benefit 
of prophylactic antioxidant supplementation (vitamin E) on 
some pregnancy health indices.
Materials and methods
A randomized clinical trial was conducted from January 
2007 to February 2008 at the Women’s Hospital of Tabriz 
University of Medical Sciences, Iran. Eligible women had 
singleton gestation with normal blood pressure both at the 
first measurement in pregnancy and repeated again at trial 
enrollment.
Eligible women with a gestational age ,14 weeks, who 
attended the maternity outpatient clinic of the Women’s 
Hospital for routine check-up, were randomly assigned to 
two groups. A 1:2 weighted simple randomization technique 
was used to allocate the patients to receive either vitamin E 
or not to receive the drug (control group). To assign patients 
to each group, an assignment list was produced using the 
random number generator rand function in Microsoft® Excel. 
Women in the vitamin E group received capsules containing 
400 IU vitamin E (RRR-alpha-tocopherol acetate; Zahravi 
Pharmaceutical Company, Tabriz, Iran) from week 14 of 
gestation to delivery time. They were asked to swallow the 
capsules without crushing or chewing them.
Women with any of the following were ineligible: 
known multiple pregnancies; specific contraindications to 
vitamin E therapy such as hemochromatosis or anticoagulant 
therapy;4 a body mass index (BMI) ,20 or .29; history of 
hypertension and proteinuria before conception or before 
20 weeks of gestation.
Gestational age was calculated based on the last   menstrual 
period date and confirmed by ultrasonography in early 
pregnancy. The participant was seated for 5 minutes, and 
then the average of two consecutive measurements taken 
3 minutes apart was recorded. Preeclampsia was diagnosed 
according to the following strict criteria: a systolic blood 
pressure of $140 mmHg, or a diastolic blood pressure 
of $90 mmHg, on two occasions at least 6 hours apart 
occurring after the 20th week of pregnancy in women with 
previously normal blood pressure, plus detectable urinary 
protein ($1 + by dipstick or $0.3 g per 24 hours).
SPSS statistical software package (v 16.0; SPSS Inc, 
Chicago, IL) was used to analyze data. Treatment group 
comparisons were summarized as differences in means or 
risk ratios and independent sample t-tests and χ2 or Fisher’s 
exact tests were applied. Values were expressed as percentage 
and mean ± SD. P values , 0.05 were considered   statistically 
significant.
The protocol was approved by the ethics committee of 
Tabriz University of Medical Sciences, and informed consent 
was obtained from all the participants.
Results
Mean gestational age at recruitment was 12.2 weeks. There 
was no statistically significant difference in maternal BMI, 
maternal age, and nulliparity between the groups (Table 1). 
In the vitamin E group, 0.96% of women were complicated 
by preeclampsia in comparison with 1.8% in the control 
group (blood pressure .140/90 mmHg and 24-hour urine 
protein .300 mg), with no statistically significant differ-
ence between the groups. The relative risk of preeclampsia 
was 0.54.
Mean birth weight was 3187 ± 545.09 g in the treated 
group and 3203.41 ± 537.96 g in the control group (P = 0.8) 
(Table 2). Mean Apgar score at both 1-minute and 5-minute 
measurements was higher in the vitamin E group than the 
control group. The difference was not statistically different 
in any of the cases, but the P-value in 5-minute Apgar score 
was 0.09 vs 0.8 for 1-minute Apgar score. Term pregnancy 
was observed in 93% of vitamin E group compared with 
90% of the control group.
Discussion
The possible positive effects of supplementary   vitamin E dur-
ing pregnancy have been studied previously by investigating 
changes in vitamin E levels in gestation or in normal vs 
problematic pregnancies. Oxidative stability of vitamin E 
levels was shown to increase in maternal blood during normal 
pregnancy.6 Also it has been shown that in some situations, 
such as smoking during pregnancy, the need for vitamin E 
may increase.7 In a study comparing abnormal and normal 
pregnancies, mean vitamin E levels rose from 12.9 µg/mL in 
early pregnancy to 22.5 µg/mL at term in normal pregnancies, 
but in pregnancies with fetal complications or maternal risks, 
levels were lower than in normal pregnancies at correspond-
ing gestational age.8 In an earlier study by Tamura et al on 
289 pregnant women in Birmingham, AL, no significant 
association was found between vitamin E serum concentra-
tions and pregnancy outcomes.9
Table 1 Mean and standard deviation of the characteristics of 
mothers and their newborns in the studied groups
Group parameter Vitamin E Control P-value
Maternal age (years) 25.29 ± 5.14 26.05 ± 5.22 0.6
nulliparous (%) 60.8 51.4 0.4
Maternal BMI (kg/m2) 25.67 ± 4.96 27.81 ± 5.11 0.9International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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An observational study showed that serum vitamin E level 
may be lower in pregnancies ending in a low-birth-weight 
delivery.8 Interestingly, however, two studies found that 
birth weight is significantly lower among those receiving 
supplementary vitamin E than in those not receiving it.10,11 
We found that birth weight did not differ between those 
receiving vitamin E and those who did not. A meta-analysis 
of the few available clinical trials found that vitamin E 
supplementation did not affect birth weight.5 Although the 
available evidence does not seem to clearly support any 
association between vitamin E and birth weight, considering 
the paucity of information, possible heterogeneity in the 
available studies, and statistical power limitations, further 
studies are needed to support stronger conclusions in this 
regard.
Preeclampsia is another outcome of interest. A small 
study found that the concentrations of vitamin E was 
significantly lower in a preeclampsia group than in a 
normotensive group at 28 weeks’ gestation.12 Another 
observational study found total antioxidant and vitamin C 
concentrations to be significantly lower in preeclamptic 
patients than in pregnant controls.13 No significant difference 
in vitamin E concentration was found among four groups 
(normotensives, mild preeclamptics, severe preeclamptics, 
and healthy nonpregnant women), but the groups were not 
large enough to support a strong conclusion. Nevertheless, 
several similar clinical trials have also been conducted 
leading to some controversy in this regard, but most were 
not in favor of the effect in preventing preeclampsia. Our 
findings do not support the hypothesis that vitamin E 
(400 IU) supplements, given prophylactically in pregnancy, 
reduce the rate of preeclampsia: the rate of preeclampsia in 
the treated group was similar to that in the control group. 
However, our study lacks adequate statistical power to make 
a strong conclusion and any interpretation based on these 
findings should be made cautiously. Several other trials 
have examined the effectiveness of vitamins C and E in 
preventing preeclampsia, using the same doses of vitamin E 
as in our trial. Several studies have shown no significant 
benefits of administering antioxidants to pregnant 
women.5,11,14 In contrast, Chappell et al found that treatment 
from early pregnancy (16 to 22 weeks) with a combination 
of 1000 mg vitamin C and 400 IU vitamin E daily in a high-
risk population can significantly (17%) reduce preeclampsia 
rate.15 However, the need to investigate the optimum dosing 
and timing of supplementary antioxidant administration has 
been discussed, since inappropriate antioxidant treatment 
in pregnant women may reduce placental cell proliferation 
and even lead to cell death.16 In a multicenter randomized 
controlled trial, in which 2647 women were assigned to daily 
treatment (1 g vitamin C and 400 IU vitamin E) or placebo, 
vitamin C and E supplementation did not reduce the rate 
of preeclampsia or gestational hypertension, but increased 
the risk of fetal loss or perinatal death and preterm prelabor 
rupture of membranes.17
In all these studies, the combined effect of vitamin C 
and E has been assessed, while the present study evaluated 
the effect of vitamin E supplementation in isolation on 
preeclampsia. Vitamin E supplementation is not reported 
to be generally contraindicated in pregnancy. Although 
vitamin E has not been reported to have major detrimental 
effects on preterm neonates or pregnant women, lower birth 
weight in women receiving vitamin E has been reported.10,15 
However, vitamin E has been shown to have positive effects 
on both the mother and the neonate in some conditions.18,19 
Numbers of adverse perinatal outcomes were small in this 
study, but were similar in both groups.
Consistent with most other published studies, our results 
also do not support the efficacy of supplementary vitamin E 
to improve pregnancy outcomes or prevent preeclampsia.
Although our descriptive findings on the effect of vitamin 
E in preventing preeclampsia were in line with   previous 
studies, lower statistical power should be considered as an 
explanation in the interpretation of the results.   Biochemical 
assessments were not performed in this study, but randomiza-
tion techniques likely assure the randomness of confounding 
in this study.
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Table 2 Maternal and prenatal outcomes
Group parameter Vitamin E Control P-value
Perinatal outcome N % N %
Low birth weight ,2500 g 8 7.6 11 6.5 0.6
1-minute neonatal Apgar ,7 4 3.8 10 5.9 0.26
5-minute neonatal Apgar ,7 0 0 4 2.4 0.26
Maternal outcomes
cesarean section 56 53.8 100 59.5 0.47
Premature labor 7 6.7 16 9.5 0.6International Journal of General Medicine
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